Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Beyond Bad Cholesterol: Scientists Uncover a Hidden Driver of Heart Disease (opens in a new tab)

scitechdaily.com · 2026-10-27

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 4 supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Four of six claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

  • 4 supported
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredThe pattern associated with LDL was mainly linked to cholesterol accumulating in artery walls.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the LDL proteomic signature was distinct from TRL/Lp(a), that the LDL multi-protein score was not associated with incident CAD after adjustment, and that TRL/Lp(a) may act beyond arterial lipid deposition. However, it does not provide enough abstract-level detail to verify the more specific statement that the LDL-associated protein pattern was mainly linked to cholesterol accumulating in artery walls.

1

Study evidence

Multivariable-adjusted proteome-wide regression in UK Biobank (n=35,269) identified plasma proteins associated with LDL, TRL, and Lp(a) concentrations across 2,918 measured proteins, with significance assessed using Bonferroni correction.

“Plasma proteins associated with LDL, TRL, and Lp(a) concentrations were identified using multivariable-adjusted regression across 2918 proteins in a primary prevention cohort based on UK Biobank (n=35,269)”
2

Study evidence

TRL multi-protein score associated with higher incident CAD after adjustment (per 1-SD).HR per 1-SD 1.16 (95% CI 1.08–1.24)

“Proteins consistently identified by both approaches were summarized into lipoprotein-specific multi-protein scores and associated with incident CAD (n=1599 events) using Cox regression.”
Claim 2 of 6Not coveredThe article says a previous study by the same research group found that counting harmful particles was the most effective way to predict future heart disease risk and that TRL and Lp(a) were more harmful per particle than LDL.View evidenceHide evidence

Why this verdict

The supplied abstract-level paper profile discusses differential per-particle atherogenicity as a motivation/interpretation, but it does not describe a previous study by the same group, does not verify that particle counting was the most effective predictor of future heart disease risk, and does not provide the claimed prior-study comparison that TRL and Lp(a) were more harmful per particle than LDL.

Claim 3 of 6SupportedResearchers at Chalmers University of Technology identified blood protein patterns that offer clues to what happens beyond cholesterol buildup in heart disease.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the core scientific claim: the paper identified plasma proteomic signatures associated with LDL, TRL, and Lp(a), then related TRL/Lp(a) protein scores and proteomic alterations to incident CAD and biological pathways beyond lipid deposition. The Chalmers affiliation itself is not verifiable from the supplied abstract-level profile, but the substantive paper claim is supported.

1

Study evidence

Multivariable-adjusted proteome-wide regression in UK Biobank (n=35,269) identified plasma proteins associated with LDL, TRL, and Lp(a) concentrations across 2,918 measured proteins, with significance assessed using Bonferroni correction.

“Plasma proteins associated with LDL, TRL, and Lp(a) concentrations were identified using multivariable-adjusted regression across 2918 proteins in a primary prevention cohort based on UK Biobank (n=35,269)”
2

Study evidence

TRL multi-protein score associated with higher incident CAD after adjustment (per 1-SD).HR per 1-SD 1.16 (95% CI 1.08–1.24)

“Proteins consistently identified by both approaches were summarized into lipoprotein-specific multi-protein scores and associated with incident CAD (n=1599 events) using Cox regression.”
Claim 4 of 6SupportedTriglyceride-rich lipoproteins (TRL) and lipoprotein(a) (Lp(a)) shared many protein patterns and signs of potentially harmful biological effects.View evidenceHide evidence

Why this verdict

The profile states that TRL and Lp(a) proteomic signatures overlapped substantially with each other, were distinct from LDL, and were enriched for inflammatory pathways. Their multi-protein scores were associated with incident CAD, and mediation findings implicated immune activation and vascular remodeling, supporting the hedged description of potentially harmful biological effects.

1

Study evidence

Multivariable-adjusted proteome-wide regression in UK Biobank (n=35,269) identified plasma proteins associated with LDL, TRL, and Lp(a) concentrations across 2,918 measured proteins, with significance assessed using Bonferroni correction.

“Plasma proteins associated with LDL, TRL, and Lp(a) concentrations were identified using multivariable-adjusted regression across 2918 proteins in a primary prevention cohort based on UK Biobank (n=35,269)”
2

Study evidence

TRL multi-protein score associated with higher incident CAD after adjustment (per 1-SD).HR per 1-SD 1.16 (95% CI 1.08–1.24)

“Proteins consistently identified by both approaches were summarized into lipoprotein-specific multi-protein scores and associated with incident CAD (n=1599 events) using Cox regression.”
Claim 5 of 6SupportedThe protein patterns associated with TRL and Lp(a) appeared to be linked to later development of heart disease and may reflect shared inflammatory and vascular pathways.View evidenceHide evidence

Why this verdict

The paper profile reports that TRL and Lp(a) multi-protein scores were associated with incident CAD, and that mediation analyses were consistent with immune activation and vascular remodeling markers mediating TRL-associated risk and part of Lp(a)-associated risk. The story’s wording is appropriately associational and hedged.

1

Study evidence

TRL multi-protein score associated with higher incident CAD after adjustment (per 1-SD).HR per 1-SD 1.16 (95% CI 1.08–1.24)

“Proteins consistently identified by both approaches were summarized into lipoprotein-specific multi-protein scores and associated with incident CAD (n=1599 events) using Cox regression.”
2

Study evidence

A high-dimensional mediation analysis estimated that 62% of the CAD risk associated with TRL concentrations was statistically mediated by proteomic alterations, with mediation findings described as linked to immune activation and vascular remodeling markers.62%

“High-dimensional mediation analysis quantified the proportion of lipoprotein-associated CAD risk explained by proteomic alterations.”
Claim 6 of 6SupportedThe researchers used proteomics, genetic data, and long-term health records to examine nearly 3,000 blood proteins.View evidenceHide evidence

As statedalmost 3,000 blood proteins

Why this verdict

The profile reports high-throughput plasma proteomics across 2,918 proteins, one-sample Mendelian randomization using genetic evidence, and Cox regression for incident CAD events in UK Biobank. “Nearly 3,000 blood proteins” is consistent with 2,918 proteins. The exact phrase “long-term health records” is not stated in the profile, but the incident CAD follow-up analysis is consistent with the story’s high-level description.

1

Study evidence

Multivariable-adjusted proteome-wide regression in UK Biobank (n=35,269) identified plasma proteins associated with LDL, TRL, and Lp(a) concentrations across 2,918 measured proteins, with significance assessed using Bonferroni correction.

“Plasma proteins associated with LDL, TRL, and Lp(a) concentrations were identified using multivariable-adjusted regression across 2918 proteins in a primary prevention cohort based on UK Biobank (n=35,269)”
2

Study evidence

Using a concordance criterion between observational proteome-wide associations and one-sample MR (both Bonferroni-adjusted P<0.05), 30 proteins were identified as associated with LDL concentrations.

“findings were corroborated using one-sample Mendelian randomization”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • External replication: the abstract states that findings were replicated in the Multi-Ethnic Study of Atherosclerosis (MESA), n=5,915.

    The story summary and claims do not mention the independent MESA replication cohort.

    From replication cohort analysis (MESA)

  • Key limitation: the discovery and CAD association analyses are observational and can be affected by residual confounding; the mediation analysis relies on strong observational causal assumptions.

    The story uses suggestive language and notes that further work is needed before measuring or targeting these processes for prevention, but it does not explicitly mention residual confounding or the strong assumptions required for observational mediation, which are interpretation-changing caveats.

    From Discovery proteome-wide association scan (observational); prospective cohort prognostic analysis (UK Biobank); High-dime

5 things the story did carry across
  • Discovery proteome-wide association scan: the study identified plasma protein signatures associated with LDL, TRL, and Lp(a) concentrations across 2,918 proteins in UK Biobank primary-prevention participants.
  • Genetic corroboration: one-sample Mendelian randomization was used to corroborate observational proteomic associations, with concordant protein sets reported for LDL, TRL, and Lp(a).
  • Incident CAD association: lipoprotein-specific multi-protein scores were tested against incident coronary artery disease; TRL and Lp(a) scores were associated with higher CAD risk, while the LDL score was not after adjustment.
  • Mediation/pathway finding: high-dimensional mediation analysis estimated that proteomic alterations mediated 62% of TRL-associated CAD risk and 14% of Lp(a)-associated risk, implicating immune activation and vascular remodeling under observational mediation assumptions.
  • Clinical interpretation: LDL lowering remains important, and the proteomic findings do not establish that measuring or targeting these processes will improve prevention.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

5

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoIdentify plasma proteomic signatures associated with concentrations of LDL, TRL, and Lp(a) in a large primary-prevention cohort and corroborate these associations using one-sample Mendelian randomization.Discovery proteome-wide association scan (observational)Expand

In plain English

In a discovery proteome-wide association scan using UK Biobank primary-prevention participants (n=35,269), multivariable-adjusted regression across 2,918 plasma proteins identified proteomic signatures associated with LDL, triglyceride-rich lipoproteins (TRL), and lipoprotein(a) concentrations. Multiple-testing correction (Bonferroni) was applied to define significant protein associations.

Key findings

  • Multivariable-adjusted proteome-wide regression in UK Biobank (n=35,269) identified plasma proteins associated with LDL, TRL, and Lp(a) concentrations across 2,918 measured proteins, with significance assessed using Bonferroni correction.
  • The proteomic signatures for TRL and Lp(a) were distinct from the LDL signature but overlapped substantially with each other and were commonly enriched for inflammatory pathways.
“Plasma proteins associated with LDL, TRL, and Lp(a) concentrations were identified using multivariable-adjusted regression across 2918 proteins in a primary prevention cohort based on UK Biobank (n=35,269)”
What this piece can’t prove
  • Abstract provides limited methodological detail (e.g., proteomic platform, exact covariates included in multivariable adjustment, and full lists/statistics for identified proteins).
  • Observational design of the discovery analysis means findings may be influenced by confounding and require orthogonal corroboration (the paper reports Mendelian randomization and replication elsewhere).
  • Use of Bonferroni correction controls family-wise error but may be conservative, potentially reducing sensitivity to detect true associations.
2human in vivoIdentify plasma proteomic signatures associated with concentrations of LDL, TRL, and Lp(a) in a large primary-prevention cohort and corroborate these associations using one-sample Mendelian randomization.one-sample Mendelian randomizationExpand

In plain English

In UK Biobank participants, the authors used one-sample Mendelian randomization (MR) to genetically corroborate plasma proteome associations with concentrations of LDL, TRL, and Lp(a). Proteins were retained as "robust" only if associations were concordant in both the observational proteome-wide scan and one-sample MR (both Bonferroni-adjusted P<0.05), yielding distinct lipoprotein-specific protein sets.

Key findings

  • Using a concordance criterion between observational proteome-wide associations and one-sample MR (both Bonferroni-adjusted P<0.05), 30 proteins were identified as associated with LDL concentrations.
  • Applying the same concordance criterion identified 471 proteins associated with TRL concentrations.
“findings were corroborated using one-sample Mendelian randomization”
What this piece can’t prove
  • Abstract does not report details of genetic instrument selection, strength, or specification for the one-sample MR analyses.
  • Abstract does not report MR sensitivity analyses (e.g., assessment of horizontal pleiotropy) or other robustness checks.

1 further detail could not be confirmed from the summary.

3human in vivoConstruct lipoprotein-specific multi-protein scores from concordant proteins and test their associations with incident coronary artery disease (CAD).prospective cohort prognostic analysis (UK Biobank)Expand

In plain English

In UK Biobank (primary prevention cohort), proteins that were concordantly associated with lipoprotein concentrations by both multivariable observational regression and one-sample Mendelian randomization were combined into lipoprotein-specific multi-protein scores; these scores were tested for association with incident coronary artery disease (n=1599 events) using Cox proportional hazards models with multivariable adjustment including measured lipoprotein concentrations. TRL- and Lp(a)-specific scores were positively associated with incident CAD (HR per 1-SD 1.16 and 1.09, respectively), whereas the LDL-specific score was not (HR per 1-SD 0.95).

Key findings

  • TRL multi-protein score associated with higher incident CAD after adjustment (per 1-SD).HR per 1-SD 1.16 (95% CI 1.08–1.24)
  • Lp(a) multi-protein score associated with higher incident CAD after adjustment (per 1-SD).HR per 1-SD 1.09 (95% CI 1.03–1.15)
“Proteins consistently identified by both approaches were summarized into lipoprotein-specific multi-protein scores and associated with incident CAD (n=1599 events) using Cox regression.”
4human in vivoQuantify how much of lipoprotein-associated CAD risk is statistically mediated by proteomic alterations (high-dimensional mediation), to illuminate biological processes underlying differential per-particle atherogenicity.High-dimensional observational mediation analysisExpand

In plain English

In the UK Biobank primary prevention cohort, a high-dimensional mediation analysis estimated the proportion of CAD risk associated with triglyceride-rich lipoproteins (TRL) and lipoprotein(a) [Lp(a)] that is statistically mediated by proteomic alterations. The analysis reported a proportion mediated of 62% for TRL and 14% for Lp(a), and interpreted these findings as consistent with mediation via immune activation and vascular remodeling markers, framed under the assumptions required for observational mediation analysis.

Key findings

  • A high-dimensional mediation analysis estimated that 62% of the CAD risk associated with TRL concentrations was statistically mediated by proteomic alterations, with mediation findings described as linked to immune activation and vascular remodeling markers.62%
  • A high-dimensional mediation analysis estimated that 14% of the CAD risk associated with Lp(a) concentrations was statistically mediated by proteomic alterations, with mediation described as present 'in part' and linked to similar inflammatory/vascular remodeling markers.14%
“High-dimensional mediation analysis quantified the proportion of lipoprotein-associated CAD risk explained by proteomic alterations.”
What this piece can’t prove
  • The abstract does not state whether the mediation results were externally validated or subjected to sensitivity analyses.

3 further details could not be confirmed from the summary.

5human in vivoReplicate key proteomic signature/score findings in an independent cohort (MESA).replication cohort analysis (MESA)Expand

In plain English

The study reports that the proteomic signatures/scores derived in the UK Biobank discovery cohort were replicated in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort (n=5,915). The abstract provides a single-line statement that replication was performed but gives no replication-specific effect estimates or detailed results.

Key findings

  • Proteomic signatures/scores derived in the UK Biobank discovery analyses were replicated in the MESA cohort (n=5,915).
“Findings were replicated in the Multi-Ethnic Study of Atherosclerosis (n=5915).”
What this piece can’t prove

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 32 candidate papers

Candidate

Association of a healthy diet score with left atrial morphology and function: a cardiac MRI study in the UK biobank cohort

European Journal of Heart Failure · 2026 · Crossref

Source (opens in a new tab)

And 26 more candidates considered.